Buy & Sell Carlyle Group Inc (CG) – Carlyle Group Inc Price Today
AI boosts pharmaceutical packaging quality, cutting defects and costs with fast ROI and regulatory compliance.
AI technology is revolutionizing pharmaceutical packaging by enabling zero-defect production and meeting strict regulatory standards. Automated AI inspection systems deliver a 315% ROI with payback under four months, improve throughput by 32%, and re...
Anthropic's Mythos AI uncovers thousands of security flaws, sparking urgent financial sector warnings.
Anthropic developed Mythos, an AI model that identifies thousands of long-standing security vulnerabilities across major software platforms, prompting the company to restrict its release. This discovery led to an emergency meeting with US financial l...
Barrel Energy becomes fully SEC reporting, boosting growth and market visibility in renewables and nutrition energy.
Barrel Energy Inc. has achieved full reporting status with the U.S. Securities and Exchange Commission, marking a key milestone in its growth strategy. This status enhances the company's transparency and marketability, allowing it to attract more inv...
FDA expands approval for Argenx's VYVGART to treat all adult generalized myasthenia gravis patients.
The FDA has approved an expanded label for Argenx's drug VYVGART, allowing its use for all adult patients with generalized myasthenia gravis (gMG), including all serotypes. This broadens the patient pool significantly and supports Argenx's growth str...
Personalized medicine market to exceed $1 trillion by 2034, driven by genomics and AI advances.
The personalized medicine market is projected to grow from USD 524 billion in 2025 to over USD 1 trillion by 2034, fueled by advances in genomics, biomarker diagnostics, and AI-powered data analytics. This growth is driven by rising chronic diseases ...
Presbyopia market to grow at 4.9% CAGR by 2036, driven by aging population and new treatments.
The global presbyopia market is projected to grow at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2036, fueled by the increasing aging population and rising prevalence of near vision impairment. Market expansion is supported by greater a...
New report details Diageo's financials, SWOT, and market position in Food & Beverages industry
ResearchAndMarkets.com released a comprehensive report on Diageo plc covering its financial performance, SWOT analysis, competitive landscape, and industry position. The report highlights Diageo's strengths like its strong brand portfolio and financi...
Lecanemab injection market to grow to $6.63B by 2030, driven by early Alzheimer's diagnosis and aging population
The global lecanemab injection market is projected to grow from $3.07 billion in 2026 to $6.63 billion by 2030, fueled by increased early-stage Alzheimer's diagnosis, FDA approvals, and expanded reimbursement policies. This growth is supported by inn...
Nvidia shifts from chipmaker to AI industry leader with strong growth and investment strategy.
Nvidia is transforming from a traditional semiconductor maker into a key architect of the AI industry by strategically investing across the entire AI value chain. The company focuses on expanding AI computing capacity, resolving supply chain issues, ...
Law firm investigates GeneDX for possible securities violations after stock drops 45% on weak revenue guidance
Block & Leviton is investigating GeneDX Holdings Corp. for potential securities law violations following a sharp 45% drop in its stock price after the company reported first quarter revenue below expectations and lowered its 2026 revenue guidance. Th...
